SENSEX NIFTY
Ranbaxy Laboratories Quarterly Results, Ranbaxy Laboratories Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
Ranbaxy Laboratories is not traded in the last 30 days
Ranbaxy Laboratories is not traded in the last 30 days
Download Annual Report PDF Format 2014 | 2011 | 2010

Quarterly Results of Ranbaxy Laboratories

------------------- in Rs. Cr. -------------------
Dec '14 Sep '14 Jun '14 Mar '14 Dec '13
Net Sales/Income from operations 956.52 1,272.69 2,116.98 1,224.59 1,327.64
Other Operating Income 53.33 46.23 61.65 27.43 38.93
Total Income From Operations 1,009.85 1,318.91 2,178.63 1,252.02 1,366.56
EXPENDITURE
Consumption of Raw Materials 314.13 335.94 280.73 394.87 432.75
Purchase of Traded Goods 228.86 227.01 184.27 224.77 219.36
Increase/Decrease in Stocks 46.07 101.17 102.74 3.29 -82.70
Power & Fuel -- -- -- -- --
Employees Cost 271.89 279.67 254.74 226.27 271.91
Depreciation 54.81 60.15 65.65 49.98 45.85
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 500.41 530.80 429.76 440.48 591.29
P/L Before Other Inc. , Int., Excpt. Items & Tax -406.32 -215.82 860.74 -87.64 -111.90
Other Income 17.75 20.02 25.76 636.50 20.60
P/L Before Int., Excpt. Items & Tax -388.56 -195.80 886.50 548.86 -91.30
Interest 149.31 136.82 141.91 110.85 118.39
P/L Before Exceptional Items & Tax -537.87 -332.63 744.59 438.02 -209.69
Exceptional Items -27.27 -35.63 19.77 490.41 -186.28
P/L Before Tax -565.14 -368.26 764.36 928.43 -395.96
Tax 855.35 -- 9.24 30.57 --
P/L After Tax from Ordinary Activities -1,420.49 -368.26 755.12 897.86 -395.96
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period -1,420.49 -368.26 755.12 897.86 -395.96
Equity Share Capital 212.24 211.95 211.78 211.66 211.55
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS -33.47 -8.69 17.83 21.22 -9.36
Diluted EPS -33.47 -8.69 17.80 21.19 -9.36
EPS After Extra Ordinary
Basic EPS -33.47 -8.69 17.83 21.22 -9.36
Diluted EPS -33.47 -8.69 17.80 21.19 -9.36
Public Share Holding
No Of Shares (Crores) 15.63 14.93 14.49 14.88 14.80
Share Holding (%) 36.77 35.22 34.18 35.11 34.93
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) 26.87 26.87 26.87 26.87 26.87
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 100.00 100.00
- Per. of shares (as a % of the total Share Cap. of the company) 63.22 63.37 63.40 63.41 63.41
Notes Notes To The Accounts
Source : Dion Global Solutions Limited

Results of Ranbaxy Labs

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for ranbaxylaboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.